Get the Stockscreener App
100.30
1.30%
1.29
After Hours:
100.01
-0.29
-0.29%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $100.30, with a volume of 11.77M.
It is up +1.30% in the last 24 hours and up +9.68% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$99.01
Open:
$98.96
24h Volume:
11.77M
Relative Volume:
0.89
Market Cap:
$248.95B
Revenue:
$63.90B
Net Income/Loss:
$19.05B
P/E Ratio:
13.27
EPS:
7.5596
Net Cash Flow:
$13.05B
1W Performance:
+0.58%
1M Performance:
+9.68%
6M Performance:
+22.59%
1Y Performance:
-0.94%
1-Day Range:
$98.31
$100.66
1-Week Range:
$96.06
$100.66
52-Week Range:
$73.31
$105.84
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
100.30 | 245.75B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,027.51 | 903.41B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
211.58 | 505.98B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
223.32 | 395.86B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
132.57 | 253.97B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Women’s Healthcare Market Worth USD 46.76 Billion by 2033 Driven by Rising Demand for Reproductive, Preventive, and Digital Health Solutions – SNS Insider - GlobeNewswire Inc.
LM Advisors LLC Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Lazard Asset Management LLC - MarketBeat
Bcwm LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Curi Capital LLC Buys 65,987 Shares of Merck & Co., Inc. $MRK - MarketBeat
Bridgeway Capital Management LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Brevan Howard Capital Management LP Buys Shares of 448,919 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Lifted by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Benjamin Edwards Inc. Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Bellevue Group AG Sells 203,132 Shares of Merck & Co., Inc. $MRK - MarketBeat
Banque Transatlantique SA Sells 418,552 Shares of Merck & Co., Inc. $MRK - MarketBeat
AQR Capital Management LLC Buys 1,029,454 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.3% After Analyst Upgrade - MarketBeat
Merck (MRK) Stock News Today: Winrevair EU Expansion, Keytruda Patent Headwinds, Analyst Forecasts and What Investors Watch (Dec. 12, 2025) - ts2.tech
Merck & Co (MRK) Analyst Ratings Update: Morgan Stanley Raises P - GuruFocus
Merck & Co., Inc. (NYSE:MRK) Given New $102.00 Price Target at Morgan Stanley - MarketBeat
Morgan Stanley Adjusts Merck & Co. PT to $102 From $100, Maintains Equalweight Rating - marketscreener.com
Merck Receives Positive EU CHMP Opinion For Expanded Use Of WINREVAIR In Adults With Pulmonary Arterial Hypertension - TradingView — Track All Markets
Peapack Gladstone Financial Corp Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Ieq Capital LLC Acquires 348,203 Shares of Merck & Co., Inc. $MRK - MarketBeat
HUB Investment Partners LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Sei Investments Co. - MarketBeat
CIBC Asset Management Inc Sells 78,956 Shares of Merck & Co., Inc. $MRK - MarketBeat
Canada Pension Plan Investment Board Has $287.91 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main - MarketBeat
Alliancebernstein L.P. Sells 1,382,219 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) S&P 500 Index Amplifies Biotech Reach - Kalkine Media
Merck & Co., Inc. (NYSE:MRK) Trading Up 1.4%Should You Buy? - MarketBeat
Merck & Co., Inc. $MRK Stock Position Decreased by The Manufacturers Life Insurance Company - MarketBeat
Investment House LLC Sells 75,437 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. (MRK) gets conditional approval for EXZOLT CATTLE-CA1 - MSN
Merck & Co., (MRK) Gets Conditional Approval For EXZOLT CATTLE-CA1 - Insider Monkey
Is It Smart To Buy Merck & Co., Inc. (NYSE:MRK) Before It Goes Ex-Dividend? - simplywall.st
NewEdge Advisors LLC Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
BNP Paribas Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
EDENTREE ASSET MANAGEMENT Ltd Purchases 15,000 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co Unusual Options Activity - Benzinga
Guggenheim lifts PT on Merck & Co. (MRK) to $122 from $104 - MSN
Guggenheim Lifts PT on Merck & Co. (MRK) to $122 From $104 - Insider Monkey
Merck & Co., Inc. $MRK Shares Sold by Intact Investment Management Inc. - MarketBeat
Stamos Capital Partners L.P. Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
HSBC Adjusts Price Target on Merck & Co. to $120 From $100, Maintains Buy Rating - marketscreener.com
Merck (NYSE:MRK) Could Be A Buy For Its Upcoming Dividend - Yahoo Finance
Diadema Partners LP Acquires New Shares in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 2%Here's What Happened - MarketBeat
Investment Management Corp of Ontario Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Cut by State Street Corp - MarketBeat
Fayez Sarofim & Co Sells 296,666 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Boosted by Daiwa Securities Group Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Federated Hermes Inc. - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):